----------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------- | An open-label, multicenter, phase Ib study investigating the effect of apalutamide on ventricular repolarization in men with castration-resistant prostate cancer |
| Belderbos Bodine P.S.I1, De Wit Ronald1, Chien Caly2, Mitselos Anna3, Hellemans Peter3, Jiao James Juhui4, Yu Margaret K.5, Attard Gerhardt6, Bulat Iurie7, Edenfield William Jeffrey8, Saad Fred9 |
1 Erasmus University Medical Center Rotterdam,
4 Janssen Research and Development, Raritan,
7 Institute of Oncology,
|
| Cancer Chemotherapy and Pharmacology |
| Nr. 3(82) / 2018 / ISSN 0344-5704 |
| Disponibil online 4 September, 2018. Descarcări-1. Vizualizări-819 |
----------------------------------------------------------------------------------------------------------------------------------- | Vericiguat: a QTc interval study in patients with coronary artery disease |
| Boettcher M.-F.1, Duengen H.-D.2, Corcea Vasile3, Donath Frank4, Fuhr Rainard5, Gal Pim6, Mikus Gerd7, Trenk Dietmar8, Werner Nils9, Pires Philippe Vieira10, Maschke Claudia11, Aliprantis Antonios Othon12, Besche Nina13, Becker Corina1 |
1 Clinical Pharmacology, Wuppertal,
2 Berlin School of Public Health, Charité-Universitätsmedizin, Berlin,
3 ”Nicolae Testemițanu” State University of Medicine and Pharmacy,
4 SocraTec R and D GmbH, Erfurt,
5 Early Phase Clinical Unit, Berlin,
6 Centre for Human Drug Research, Leiden,
8 University Medical Center Freiburg,
10 Research and Development, Bayer AG, Wuppertal,
11 Study Management, Bayer AG, Wuppertal,
12 Translational Medicine, Merck and Co., Inc., New Jersey ,
13 Chrestos Concept GmbH and Co. KG, Essen |
| European Heart Journal |
| Nr. / 2021 / ISSN 0195-668X |
| Disponibil online 30 March, 2024. Descarcări-0. Vizualizări-49 |
----------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------- | Pharmacokinetics, Dialysability, and Safety of Gadopiclenol, a New Gadolinium-Based Contrast Agent, in Patients with Impaired Renal Function |
| Bradu Andrei1, Penescu Mircea Nicolae2, Pitrou Camille3, Hao Jing3, Bourrinet Philippe3 |
1 ”Nicolae Testemițanu” State University of Medicine and Pharmacy,
2 University of Medicine and Pharmacy “Carol Davilla”, Bucharest,
3 Guerbet, Roissy CDG Cedex |
| Investigative Radiology |
| Nr. 8(56) / 2021 / ISSN 0020-9996 /ISSNe 1536-0210 |
| Disponibil online 2 August, 2021. Descarcări-0. Vizualizări-471 |
----------------------------------------------------------------------------------------------------------------------------------- -----------------------------------------------------------------------------------------------------------------------------------
1-8 of 8
